Year: 2025
Language: English
This information sheet is designed to help understand the similarities, differences, and current state of knowledge for the existing genetic technologies for hemophilia.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
The World Federation of Hemophilia (WFH) hosted an educational webinar titled “Progress toward a cure for hemophilia: gene editing explained”
A summary of discussions held at the Thirteenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
A summary of discussions held at the Twelfth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
The 3rd edition of the WFH laboratory Manual is the definitive how-to guide for the accurate diagnosis of hemophilia and
The WFH Shared Decision Making (SDM) Workbook is for people with hemophilia A or B and their healthcare team. It
This paper provides an overview of the Turkish method for circumcision in people with hemophilia, as well as appendices of
